The Effect of Methods Used During Blood Collection on Pain and Fear in Children (pain and fear)

April 29, 2025 updated by: Hatice ŞEN

The Effect of Three Different Methods Used During Blood Collection in Children on Pain, Fear and Procedure Time

The effect of three different methods (local skin cooling device, bubble machine, simulative toy) that will be used during the blood collection procedure on pain, fear and procedure time will be investigated in pain-sensitive 6-12 age group children.

Study Overview

Detailed Description

Children are usually admitted to the hospital for diagnosis, treatment or follow-up at an early stage of their lives and are subjected to various invasive procedures during this process. Blood collection is one of the interventions that are repeated many times by children during diagnosis and treatment, causing a feeling of pain and fear. Although bloodletting may seem like a minor procedure, it is considered a source of great fear by children and therefore turns into an unpleasant experience by both children and their families.

Pain management is both an ethical obligation and a child's right, which should be done by focusing on the needs and preferences of children and their parents, requires accurate and effective planning. Nonpharmacological treatment methods used in pain management in children are classified into three groups: physical, supportive and cognitive-behavioral methods. The use of Coolsense, a local skin cooling device, is a method that can be used in this sense in terms of its rapid effect. Coolsense; it is a hand-held device that has an effect in as little as five seconds, does not contain chemicals, has a temperature-controlled head, can be stored in the freezer of refrigerators and used repeatedly. Among the advantages of the device are that it is easy to use, it is applied to a small area and it is easy to Decipher whether it is at the right temperature from the light burning on it. The most preferred method among cognitive-behavioral methods is the method of diverting attention Decently. The method of diverting attention is divided into two as active and passive methods. One of the methods of attracting active attention is the use of toys. One of these toys is a bubble machine. The bubble machine is a toy with the ability to produce a large number of bubbles at the same time with its multi-hole design. With this toy, the child focuses on the bubbles that come out through the bubble machine, and not on the painful process, so his attention is diverted from the blood collection process. Another one of the toys is a simulative toy. Simulative toy; it is a toy that can show realistic and vivid features, contains sensors sensitive to touch and movement, breathes, can open and close its eyes, can move its head and body, and at the same time make sounds as if it were real. With these features, it can be effective in reducing pain and fear by ensuring that children's attention is diverted from the painful procedure. It is thought that three different methods (local skin cooling device, bubble machine, simulative toy) that will be used during the blood collection procedure in pain-sensitive 6-12 age group children may have a positive effect on pain, fear and procedure time.

Study Type

Interventional

Enrollment (Estimated)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • The child must be between the ages of 6 and 12.
  • The child's WB-YİDÖ score must be 0 before the blood collection procedure.
  • The child must be willing to participate in the study and sign the Informed Consent Form/Written Consent Form.
  • The child must be able to speak Turkish.
  • The child must not have a mental disability and must be able to use their arms functionally.
  • The child must not have used sedatives, analgesics, or narcotics within 6 hours prior to admission to the blood collection unit.
  • The child's body temperature must be below 38 °C at the time of admission to the blood collection unit.
  • The child must have undergone blood collection procedures before.
  • The child must not be afraid of the simulation toy.

Exclusion Criteria:

  • Failure to sign the Informed Consent Form/Written Consent Form.
  • The child has a disease that causes chronic pain.
  • The child has vision or hearing problems.
  • Deterioration of skin integrity in the blood collection area or in the area where the local skin cooling device will be applied.
  • Presence of nerve damage in the area where blood will be drawn.
  • Having sensory motor deficit, diabetes, peripheral vascular disease (e.g., Raynaud's syndrome), neuropathy, or sickle cell anemia.
  • The child has an allergy to the simulative toy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Local Skin Cooling Device Group
Participants are given a cold application using a local skin cooling device just before the blood collection process.
Immediately before the blood collection procedure, cold application will be made to the area with a local skin cooling device.
Experimental: Bubble Machine Group
During the blood collection process, participants are entertained with the bubble machine.
A bubble machine will be used to distract children during the blood collection process.
Experimental: Simulative Toy Group
During the blood collection process, participants are distracted with a simulative toy.
A simulative toy will be used to distract children during the blood collection process.
No Intervention: Control Group
Participants are not subjected to any intervention during the blood collection process.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wong-Baker Facial Expressions Rating Scale
Time Frame: At the time of blood collection (0 minutes) and 5 minutes after the procedure
The Wong-Baker Facial Expressions Rating Scale will be used to assess the pain levels of children during the blood collection procedure and 5 minutes after the procedure. The scale includes six facial expressions representing increasing levels of pain, scored from 0 (no pain) to 5 or 10 (severe pain), depending on the version used.
At the time of blood collection (0 minutes) and 5 minutes after the procedure
Children's Fear Scale
Time Frame: Immediately before and during the blood collection procedure.
The Child Fear Scale, which is suitable for children aged 3 to 16, will be used to assess the level of fear and anxiety experienced by the child before and during the blood collection. The scale consists of five facial expressions scored from 0 (no fear and anxiety) to 4 (highest fear and anxiety), and can be administered by children, parents, or researchers.
Immediately before and during the blood collection procedure.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 12, 2025

Primary Completion (Estimated)

November 28, 2025

Study Completion (Estimated)

December 31, 2025

Study Registration Dates

First Submitted

April 20, 2025

First Submitted That Met QC Criteria

April 29, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 29, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • University Mersin

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Cold Application (Local Skin Cooling Device)

Subscribe